Literature DB >> 21633850

Multiple calcified primary central nervous system lymphoma with immunodeficiency in a child.

Jing-Qi Zhu1, Nan-Xin Hao, Wei-Qun Bao, Xiang-Ru Wu.   

Abstract

BACKGROUND: Multiple calcified primary central nervous system lymphoma (PCNSL) is extremely rare in childhood.
METHODS: We report a 4-year-old boy suffering from multiple calcified B-cell lymphoma in the brain with immunodeficiency.
RESULTS: The boy had a history of walking weakness and seizure for 4 months. The serum levels of immunoglobulin G, A and M were decreased. Brain MRI showed multiple lesions which had ring enhancement. CT showed calcification in all of the lesions. The boy was firstly misdiagnosed with multiple chronic brain abscesses. Pathological analysis of biopsy confirmed the diagnosis of anaplastic diffuse large B-cell lymphoma.
CONCLUSION: PCNSL should be included in the differential diagnosis of intracranial mass with calcification.

Entities:  

Mesh:

Year:  2011        PMID: 21633850     DOI: 10.1007/s12519-011-0311-7

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  13 in total

1.  A case series of pediatric primary central nervous system lymphoma: favorable outcome without cranial irradiation.

Authors:  Oussama Abla; John T Sandlund; Lillian Sung; Penelope Brock; Rob Corbett; Ivan Kirov; Timothy C Griffin; Susan Blaser; Sheila Weitzman
Journal:  Pediatr Blood Cancer       Date:  2006-12       Impact factor: 3.167

2.  Nonenhancing primary central nervous system lymphoma.

Authors:  S Terae; A Ogata
Journal:  Neuroradiology       Date:  1996-01       Impact factor: 2.804

3.  Primary malignant lymphoma of the central nervous system in an immunocompetent child: a case report.

Authors:  Yusuke Shiozawa; Nobutaka Kiyokawa; Junya Fujimura; Kyoko Suzuki; Yukiko Yarita; Junichiro Fujimoto; Masahiro Saito; Yuichiro Yamashiro
Journal:  J Pediatr Hematol Oncol       Date:  2005-10       Impact factor: 1.289

Review 4.  Pediatric primary CNS lymphoma: longterm survival after treatment with radiation monotherapy.

Authors:  K Makino; H Nakamura; S Yano; J-I Kuratsu
Journal:  Acta Neurochir (Wien)       Date:  2007-01-31       Impact factor: 2.216

5.  Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients.

Authors:  A Coulon; F Lafitte; K Hoang-Xuan; N Martin-Duverneuil; K Mokhtari; J Blustajn; J Chiras
Journal:  Eur Radiol       Date:  2001-09-21       Impact factor: 5.315

6.  Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications.

Authors:  B K Kleinschmidt-DeMasters; Denise M Damek; Kevin O Lillehei; Ahmed Dogan; Caterina Giannini
Journal:  J Neuropathol Exp Neurol       Date:  2008-11       Impact factor: 3.685

Review 7.  Primary central nervous system lymphoma.

Authors:  H A Fine; R J Mayer
Journal:  Ann Intern Med       Date:  1993-12-01       Impact factor: 25.391

Review 8.  Characterization of primary intracranial lymphoma by computed tomography: an analysis of 36 cases and a review of the literature with particular reference to calcification haemorrhage and cyst formation.

Authors:  C N Jenkins; I R Colquhoun
Journal:  Clin Radiol       Date:  1998-06       Impact factor: 2.350

9.  Radiographic findings in 32 cases of primary CNS lymphoma.

Authors:  C R Jack; D F Reese; B W Scheithauer
Journal:  AJR Am J Roentgenol       Date:  1986-02       Impact factor: 3.959

Review 10.  Primary central nervous system lymphoma.

Authors:  Sharathkumar Bhagavathi; Jon D Wilson
Journal:  Arch Pathol Lab Med       Date:  2008-11       Impact factor: 5.534

View more
  1 in total

1.  Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma.

Authors:  Heike Thorer; Martin Zimmermann; Olga Makarova; Ilske Oschlies; Wolfram Klapper; Peter Lang; Arend von Stackelberg; Gudrun Fleischhack; Jennifer Worch; Heribert Juergens; Wilhelm Woessmann; Alfred Reiter; Birgit Burkhardt
Journal:  Haematologica       Date:  2014-08-08       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.